Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/EBEFCAF777A6D642BC536C70B4783E0CC8312349987BF5ECE1B5D8FCA97C52A9886E181AD219BD804A2F3657B97DCF6Bhttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/EBEFCAF777A6D642BC536C70B4783E0CC8312349987BF5ECE1B5D8FCA97C52A9886E181AD219BD804A2F3657B97DCF6Bhttp://www.w3.org/2000/01/rdf-schema#comment"Clinical trial of gene-disease association gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator); These data suggest that the PGC-1alpha Thr394Thr and Gly482Ser polymorphisms are associated with therapeutic efficacy of multiple-dose rosiglitazone in Chinese patients with type 2 diabetes mellitus."xsd:string
http://purl.uniprot.org/uniprot/#_3779AFBACA4A55D0C15CF1184A4A271664DC29548B9F72CAF25618C0F8AEE34EAD268B5941D1F4F304065EE6FB955E85http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/EBEFCAF777A6D642BC536C70B4783E0CC8312349987BF5ECE1B5D8FCA97C52A9886E181AD219BD804A2F3657B97DCF6B
http://purl.uniprot.org/uniprot/Q9UBK2http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/EBEFCAF777A6D642BC536C70B4783E0CC8312349987BF5ECE1B5D8FCA97C52A9886E181AD219BD804A2F3657B97DCF6B
http://purl.uniprot.org/uniprot/#_Q9UBK2-mappedCitation-20498286http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/EBEFCAF777A6D642BC536C70B4783E0CC8312349987BF5ECE1B5D8FCA97C52A9886E181AD219BD804A2F3657B97DCF6B